The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS
Abstract Purpose Rapid development of novel therapeutics in renal cell carcinoma (RCC) has led to financial burden for patients and society. Value including clinical benefit, toxicity affecting quality of life and cost-effectiveness are a concern, prompting the need for tools to facilitate value ass...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2022-07-01
|
| Σειρά: | BMC Health Services Research |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12913-022-08279-6 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|